(S (NP (NP (DT The) (NN speed)) (SBAR (WHPP (IN with) (WHNP (WDT which))) (S (NP (JJ biomedical) (NNS researchers)) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB identify) (CC and) (VB characterise) (NP (NN COVID) (HYPH -) (CD 19)))))))))) (VP (VBD was) (ADJP (RB clearly) (JJ due) (PP (IN to) (NP (JJ prior) (NN research)))) (PP (IN with) (NP (JJ other) (NNS coronaviruses)))) (. .))
(S (NP (NP (NP (RB Early) (JJ epidemiological) (NNS comparisons)) (PP (IN with) (NP (CD two) (JJ previous) (NNS coronaviruses)))) (, ,) (NP (NP (NP (JJ Severe) (NNP Acute) (NNP Respiratory) (NNP Syndrome)) (-LRB- -LRB-) (NP (NNP SARS)) (-RRB- -RRB-)) (CC and) (NP (NP (NNP Middle) (NNP East) (NNP Respiratory) (NNP Syndrome)) (-LRB- -LRB-) (NP (NNP MERS)) (-RRB- -RRB-))) (, ,)) (ADVP (RB also)) (VP (VBD made) (S (NP (PRP it)) (ADJP (JJR easier)) (S (VP (TO to) (VP (VB predict) (NP (NP (NP (NNP COVID) (HYPH -) (NNP 19) (POS 's)) (JJ likely) (NN spread)) (CC and) (NP (NN lethality)))))))) (. .))
(S (NP (DT This) (NN article)) (VP (VBZ assesses) (SBAR (IN whether) (S (NP (NP (JJ academic) (NN interest)) (PP (IN in) (NP (JJ prior) (NN coronavirus) (NN research)))) (VP (VBZ has) (VP (VBN translated) (PP (IN into) (NP (NN interest))) (PP (IN in) (NP (DT the) (JJ primary) (NN source) (NN material))) (, ,) (S (VP (VBG using) (NP (NNP Mendeley) (NN reader) (NNS counts)) (PP (IN for) (NP (JJ early) (JJ academic) (NN impact) (NN evidence)))))))))) (. .))
(S (NP (DT The) (NNS results)) (VP (VBP confirm) (SBAR (IN that) (FRAG (NP (NNP SARS) (CC and) (NNP MERS)) (NP (NP (NN research) (CD 2008) (HYPH -) (CD 2017)) (NP (JJ experienced) (ADJP (RB anomalously) (JJ high)) (NNS increases))) (PP (IN in) (NP (NP (NNP Mendeley) (NNS readers)) (PP (IN in) (NP (NNP April) (HYPH -) (NNP May))) (NP-TMP (CD 2020))))))) (. .))
(S (ADVP (RB Nevertheless)) (, ,) (NP (NP (NNS studies)) (VP (VP (VBG learning) (NP (NML (NNP COVID) (HYPH -) (CD 19)) (NNS lessons)) (PP (IN from) (NP (NNP SARS) (CC and) (NNP MERS)))) (CC or) (VP (VBG using) (NP (PRP them)) (PP (IN as) (NP (NP (DT a) (NN benchmark)) (PP (IN for) (NP (NN COVID) (HYPH -) (CD 19)))))))) (VP (VBP have) (VP (VBN generated) (NP (ADJP (RB much) (RBR more) (JJ academic)) (NN interest)) (PP (IN than) (NP (NP (JJ primary) (NNS studies)) (PP (IN of) (NP (NNP SARS) (CC or) (NNP MERS))))))) (. .))
(S (ADVP (RB Thus)) (, ,) (NP (NP (NN research)) (SBAR (WHNP (WDT that)) (S (VP (VBZ interprets) (NP (NP (JJ prior) (JJ relevant) (NN research)) (PP (IN for) (NP (NP (JJ new) (NNS diseases)) (SBAR (WHADVP (WRB when)) (S (NP (PRP they)) (VP (VBP are) (VP (VBN discovered)))))))))))) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (ADJP (RB particularly) (JJ important) (S (VP (TO to) (VP (VB help) (NP (NNS researchers)) (S (VP (TO to) (VP (VB understand) (NP (PRP$ its) (NNS implications)) (PP (IN in) (NP (DT the) (JJ new) (NN context)))))))))))))) (. .))
